H. Pylori

November 4th 2019

RHB-105 (Talicia) is the only rifabutin-based therapy approved for the treatment of H pylori infection and is designed to address the high resistance of H pylori bacteria to current clarithromycin-based standard-of-care therapies.

October 23rd 2019

Helicobacter pylori resistance to clarithromycin more than doubled during the past 20 years, according to new research presented at UEG Week Barcelona 2019.

April 11th 2017

In a recent study, researchers from several institutions found that individuals from North, Central, and South Americas may be at an increased risk of cancer due to Heliobacter pylori strains brought over to the "New World" with European explorers.

April 5th 2017

News on Heliobacter pylori, Zika, Clostridium difficile, Powassan virus, and influenza make up the top 5 news articles from Contagion® in March 2017.